4.5 Article

Whole exome sequencing identifies a novel homozygous MECR mutation in a Chinese patient with childhood-onset dystonia and basal ganglia abnormalities, without optic atrophy

期刊

MITOCHONDRION
卷 57, 期 -, 页码 222-229

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.mito.2020.12.014

关键词

Dystonia; Basal ganglia; MECR; Mitochondrial fatty acid synthesis; Lipoic acid

资金

  1. Capital Health Development Research Foundation Project [2018-2-2096]
  2. National Natural Science Foundation of China [81541115]
  3. Practical Research Project for Rare/Intractable Diseases from the Agency for Medical Research and Development (AMED), Japan [JP20ek0109468, JP19ek0109273]

向作者/读者索取更多资源

This study reported a rare case of MECR-related mitochondrial disease in a Chinese patient, presenting with childhood-onset dystonia and basal ganglia abnormalities but no optic atrophy. Disease progression was controlled with lipoic acid treatment, and visual impairment was not observed.
Childhood-onset dystonia with optic atrophy and basal ganglia abnormalities is an extremely rare autosomal recessive mitochondrial disease caused by biallelic mutations in MECR. Using whole-exome sequencing, we identified a novel homozygous MECR mutation (c.910G > T, p.Asp304Tyr) in a Chinese patient with childhoodonset dystonia and basal ganglia abnormalities, without optic atrophy. With lipoic acid treatment, the disease progression was under control, and neither visual impairment nor optic atrophy was observed. To our knowledge, this is the first study about MECR-related mitochondrial disease in a Chinese patient and the first to report that supplementation with lipoic acid is a possible effective therapeutic strategy for this disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据